Are you familiar with what 'expanded access' means?

"It is my understanding that 'expanded access' is granted, under certain circumstances, to patients who do not qualify to participate in a clinical trial of a regulatory drug. The drug used in expanded access cannot expose patients to unreasonable risks given the severity of the disease to be treated, and the patient must not have any other satisfactory therapeutic options."

"I do have some knowledge about 'expanded access,' although I have not worked directly with patients who have been granted expanded access. The manufacturer must be willing to make the drug available for expanded access use. The primary intent of expanded access is to provide treatment for a patient's disease or condition, rather than collect data about the study drug."

Focus on showing the interviewer you are familiar with the terminology used in the industry. Provide a brief description explaining expanded access.